ARQIS advises Medizintechnik Rostock on sale to SHS Capital

Rostock/ Tübingen/ Düssel­dorf — ARQIS has provi­ded legal advice to the share­hol­ders of Medi­zin­tech­nik Rostock GmbH (MTR) on the sale of a majo­rity stake to SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment mbH. SHS acqui­res the share­hol­ding for its sixth fund gene­ra­tion (SHS IV) and thus secu­res the corpo­rate succes­sion of MTR. The two previous share­hol­ders and mana­ging direc­tors of MTR will remain asso­cia­ted with MTR through a signi­fi­cant share­hol­ding. The parties invol­ved have agreed not to disc­lose further details, such as the purchase price. Medi­zin­tech­nik Rostock GmbH, with main loca­ti­ons in Rostock and Berlin, is a medium-sized company that supplies pati­ents with therapy devices for home use. MTR is one of the leading therapy and reha­bi­li­ta­tion provi­ders and, as a part­ner of 80 health insu­rance compa­nies, carried out over 140,000 treat­ments in move­ment, elec­tri­cal and compres­sion therapy in 2023. SHS Gesell­schaft für Betei­li­gungs­ma­nage­ment mbH, based in Tübin­gen, is a private equity fund that specia­li­zes in invest­ments in the health­care sector. SHS is curr­ently inves­t­ing from its sixth fund, which was laun­ched in 2022 and has a volume of around 270 million euros. The share­hol­ders and MTR have been advi­sed on health­care law for many years by a team from D+B Rechts­an­wälte Part­ner­schaft mbB led by Dr. Ulrich Grau, who recom­men­ded ARQIS for this tran­sac­tion. The team led by Dr. Jörn-Chris­­tian Schulze then prevai­led in a pitch. 

Advi­sor Medi­zin­tech­nik Rostock GmbH: ARQIS (Düssel­dorf)

Dr. Jörn-Chris­­tian Schulze (Lead Part­ner), Seve­rin Stef­fens (Mana­ging Asso­ciate, both Tran­sac­tions), Part­ners: Thomas Chwa­lek (Tran­sac­tions), Dr. Ulrich Lien­hard (Real Estate), Marcus Noth­hel­fer (IP), Coun­sel: Jens Knip­ping, Dennis Reisich (both Tax), Anja Mehr­tens (HR Law), Mana­ging Asso­cia­tes: Tim Brese­mann, Diana Pucho­wezki (both Real Estate), Daniel Schle­mann (Data Law), Nora Strat­mann (Commer­cial), Rolf Tichy (IP), Martin Wein­gärt­ner (Pensi­ons), Asso­cia­tes: Rebecca Gester (Commer­cial), Thomas Lipsky (IP), Jasmin Grünen (Tran­sac­tions), Sabine Müller, Dr. Hendrik Völker­ding (both HR Law), Senior Legal Specia­list: Qing Xia (Tran­sac­tions) D+B (Berlin)

Dr. Ulrich Grau (lead), Nicole Jesche, Tatjana Teter­ju­kow, Fran­ziska Dick­mann (all Health Law), Dr. Sabrina Neuen­dorf (Data Protec­tion Law) About ARQIS

ARQIS is an inde­pen­dent commer­cial law firm opera­ting internationally.

Around 80 lawy­ers and legal specia­lists advise dome­stic and foreign compa­nies at the highest level on German, Euro­pean and Japa­nese commer­cial law. With its focus groups Tran­sac­tions, HR Law, Japan, Data Law, Risk and Regu­la­tory, the firm is geared towards provi­ding its clients with compre­hen­sive advice. The law firm was foun­ded in 2006 and has offices in Düssel­dorf, Munich and Tokyo as well as a talent hub in Berlin. http://www.arqis.com.